{"id":227762,"date":"2025-12-24T10:15:08","date_gmt":"2025-12-24T16:15:08","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/12\/phase-3-trial-of-t-dxd-initiated-in-her2-endometrial-cancer"},"modified":"2025-12-24T10:15:08","modified_gmt":"2025-12-24T16:15:08","slug":"phase-3-trial-of-t-dxd-initiated-in-her2-endometrial-cancer","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/12\/phase-3-trial-of-t-dxd-initiated-in-her2-endometrial-cancer","title":{"rendered":"Phase 3 Trial of T-DXd Initiated in HER2+ Endometrial Cancer"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/phase-3-trial-of-t-dxd-initiated-in-her2-endometrial-cancer2.jpg\"><\/a><\/p>\n<p>AstraZeneca and Daiichi Sankyo have initiated DESTINY-Endometrial02, a global phase 3 trial evaluating fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) as an adjuvant treatment for patients with HER2-expressing endometrial cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca and Daiichi Sankyo have initiated DESTINY-Endometrial02, a global phase 3 trial evaluating fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) as an adjuvant treatment for patients with HER2-expressing endometrial cancer.<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-227762","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/227762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=227762"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/227762\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=227762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=227762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=227762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}